J

Researcher Profile

Jessica C Hassel

3

Publications

2,461

Citations

10

Co-Authors

3

Active Years

Publications

Journal Article The Lancet Sep 01, 2023

Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial

Jürgen C Becker · Selma Ugurel · Ulrike Leiter · Friedegund Meier +56 more

10.1016/s0140-6736(23)00769-9 61 citations

Open Access Journal Article Journal for ImmunoTherapy of Cancer Jul 01, 2021

First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study

Sandra P D'Angelo · Celeste Lebbe · Laurent Mortier · Andrew S Brohl +11 more

10.1136/jitc-2021-002646 105 citations

Journal Article The Lancet Oncology Apr 01, 2015

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial

Jeffrey S Weber · Sandra P D'Angelo · David Minor · F Stephen Hodi +24 more

10.1016/s1470-2045(15)70076-8 2,295 citations

Publication Timeline

2023

1

2021

1

2015

1

Frequent Co-Authors

Sandra P D'Angelo

Jean-Jacques Grob

Winan van Houdt